NOW AT OUR NEW LOCATION:
Amarimed of Colorado
2257 S. Broadway
Denver, CO 80210
NOW AT OUR NEW LOCATION:
Amarimed of Colorado
2257 S. Broadway
Denver, CO 80210
| |
Do you suffer from a debilitating medical condition?Call 720-532-4744 for a Recommendation, or click here to contact us via email. Do you suffer from a debilitating medical condition?Call 720-532-4744 for a Recommendation, or click here to contact us via email. |
|
|
Watch Dr. Shackelford on 9News
Doctor believes more physicians will recommend medical marijuana
KUSA - Dr. Alan Shackelford has been practicing medicine for 26 years.
Read the Article >Watch the video >Watch Dr. Shackelford on 9News
Doctor believes more physicians will recommend medical marijuana
KUSA - Dr. Alan Shackelford has been practicing medicine for 26 years.
Read the Article >Watch the video > |
|
|
|
Putting the “medical” in medical marijuana
We invite you to read our blog with Dr. Alan Shackelford, a Harvard trained physician and researcher. Each week, Dr. Shackelford discusses what the "medical" in medical marijuana actually means.
THIS WEEK:
Cannabinoids in Alzheimer’s Disease, Part II
You may recall from last week’s installment that some 35 million people worldwide and 5.5 million in the United States have been diagnosed with Alzheimer’s disease, equating to about 5% of people between the ages of 65 and 74 and nearly 50% of people over 85. You may also recall that the numbers appear to be increasing, and that an estimated 10 to 11 million Americans will have been diagnosed with Alzheimer’s disease by 2050.
The cause of the disease is not known. It has been postulated that a combination of genetic, environmental and lifestyle factors may be responsible for the changes in the brain that are associated with Alzheimer’s disease. Although the exact causes of the disease are not well understood, its effects are familiar to millions of people. Early in its course the disease causes difficulty remembering recent events or recently acquired facts, and mild confusion. These symptoms usually worsen over time, with additional symptoms of word-finding difficulty, disorientation, anger, aggression, agitation, loss of appetite and weight loss, depression, or withdrawal becoming increasingly likely. Ultimately, the patient is no longer able to carry out even the simplest tasks of daily living and requires full-time care. The disease also invariably shortens life expectancy, with a median survival of 7 years after diagnosis; only 3% of patients live more than 14 years after the diagnosis is made.
Read More Here >
Putting the “medical” in medical marijuana
We invite you to read our blog with Dr. Alan Shackelford, a Harvard trained physician and researcher. Each week, Dr. Shackelford discusses what the "medical" in medical marijuana actually means.
THIS WEEK:
Cannabinoids in Alzheimer’s Disease, Part II
You may recall from last week’s installment that some 35 million people worldwide and 5.5 million in the United States have been diagnosed with Alzheimer’s disease, equating to about 5% of people between the ages of 65 and 74 and nearly 50% of people over 85. You may also recall that the numbers appear to be increasing, and that an estimated 10 to 11 million Americans will have been diagnosed with Alzheimer’s disease by 2050.
The cause of the disease is not known. It has been postulated that a combination of genetic, environmental and lifestyle factors may be responsible for the changes in the brain that are associated with Alzheimer’s disease. Although the exact causes of the disease are not well understood, its effects are familiar to millions of people. Early in its course the disease causes difficulty remembering recent events or recently acquired facts, and mild confusion. These symptoms usually worsen over time, with additional symptoms of word-finding difficulty, disorientation, anger, aggression, agitation, loss of appetite and weight loss, depression, or withdrawal becoming increasingly likely. Ultimately, the patient is no longer able to carry out even the simplest tasks of daily living and requires full-time care. The disease also invariably shortens life expectancy, with a median survival of 7 years after diagnosis; only 3% of patients live more than 14 years after the diagnosis is made.
Read More Here >
| |
Did You Know?
Did you know that certain powerfully anti-inflammatory compounds in cannabis are at least as effective as medications like aspirin, ibuprofen and indomethacin for arthritis, and that as many as 16,500 people with arthritis die each year from the effects of such medications? Number of people who have died using cannabis to treat their arthritis: 0.
Amarimed patients are in the know. Sign up to receive our informative newsletter. Click Here >
Did You Know?
Did you know that certain powerfully anti-inflammatory compounds in cannabis are at least as effective as medications like aspirin, ibuprofen and indomethacin for arthritis, and that as many as 16,500 people with arthritis die each year from the effects of such medications? Number of people who have died using cannabis to treat their arthritis: 0.
Amarimed patients are in the know. Sign up to receive our informative newsletter. Click Here >
| |
|